EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab

Dagmar von Bubnoff, Christina Schmitt iD, Simone M Goldinger, Dirk Schadendorf, Katharina C Kähler, Christian Hafner, Nora Kramer, Waltraud Fröhlich, Reinhard Dummer iD, Carola Berking, Stefan Schliep, Michael C Kirchberger und 1 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0321937 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS One, 2025. Verfasst von Dagmar von Bubnoff und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University Hospital Lübeck, Lübeck, Germany. Hauptthemen laut MEDLINE: Indoleamine-Pyrrole 2,3,-Dioxygenase, Melanoma, Ipilimumab, Skin Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Verein zur Förderung des Tumorzentrums der Universität Erlangen-Nürnberg e.V..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The tumor microenvironment is crucial for prognosis and response to immunotherapy in several tumor entities.

Methods

In a multicenter retrospective study, a total of 86 tumor samples from patients with metastatic melanoma were evaluated for baseline expression of indoleamine 2,3-dioxygenase (IDO) and programmed death ligand 1 (PD-L1). Expression patterns of IDO and PD-L1 on tumor cells and antigen-presenting cells (APCs) as determined by immunohistochemical (IHC) staining of paraffin-embedded tissue sections were correlated with response to ipilimumab and overall survival (OS). Statistical analysis was performed using the Spearman correlation, the Mann-Whitney test and Kaplan-Meier estimator.

Results

IDO expression in tumor cells or APCs was not predictive for treatment response. The median OS was 26 months in IDO-positive and IDO-negative patients, regardless of IDO expression in tumor cells or APCs. A correlation of IHC expression scores of IDO and PD-L1 could not be documented.

Conclusion

The exact role of IDO in creating an immunosuppressive tumor environment and its reversal needs to be further elucidated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Indoleamine-Pyrrole 2,3,-DioxygenaseMelanomaIpilimumabSkin NeoplasmsAntineoplastic Agents, ImmunologicalHumansMaleFemaleMiddle AgedPrognosisRetrospective StudiesAgedB7-H1 AntigenAdultTumor MicroenvironmentAged, 80 and overNeoplasm MetastasisBiomarkers, Tumor

Substanzen

Indoleamine-Pyrrole 2,3,-DioxygenaseIpilimumabB7-H1 AntigenCD274 protein, humanAntineoplastic Agents, ImmunologicalBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Dermatology, University Hospital Lübeck, Lübeck, Germany.
  • Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Department of Dermatology, University Hospital of Zurich, Zürich, Switzerland.
  • Department of Dermatology, University Hospital Essen, Essen, Germany.
  • Department of Dermatology, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Department of Dermatology, University Hospital Regensburg, Regensburg, Germany.

ORCID-Profile: Christina Schmitt, Reinhard Dummer

Förderung

  • Verein zur Förderung des Tumorzentrums der Universität Erlangen-Nürnberg e.V.

Zitieren

APA

von Bubnoff, D., Schmitt, C., Goldinger, S. M., Schadendorf, D., Kähler, K. C., Hafner, C., Kramer, N., Fröhlich, W., Dummer, R., Berking, C., Schliep, S., Kirchberger, M. C., & Heinzerling, L. (2025). Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab. PLOS One. https://doi.org/10.1371/journal.pone.0321937

Vancouver

von Bubnoff D, Schmitt C, Goldinger SM, Schadendorf D, Kähler KC, Hafner C, et al. Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab. PLOS One. 2025. doi:10.1371/journal.pone.0321937

BibTeX
@article{vonBubnoff2025,
  author = {von Bubnoff, Dagmar and Schmitt, Christina and Goldinger, Simone M and Schadendorf, Dirk and Kähler, Katharina C and Hafner, Christian and Kramer, Nora and Fröhlich, Waltraud and Dummer, Reinhard and Berking, Carola and Schliep, Stefan and Kirchberger, Michael C and Heinzerling, Lucie},
  title = {Prognostic and predictive value of IDO expression in metastatic melanoma treated with Ipilimumab},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0321937}
}
Kostenlos starten →